Asymptomatic carriers and gender differences in facioscapulohumeral muscular dystrophy (FSHD)
- PMID: 14659410
- DOI: 10.1016/j.nmd.2003.07.001
Asymptomatic carriers and gender differences in facioscapulohumeral muscular dystrophy (FSHD)
Abstract
Facioscapulohumeral muscular dystrophy is an autosomal dominant muscle disorder, mapped to 4q35. It is characterized by remarkable inter- and intrafamilial clinical variability ranging from severe phenotype to asymptomatic carriers. The aim of the present study was to assess the size of the Eco RI fragment in a large sample of asymptomatic or minimally affected carriers as well as symptomatic patients, comparing both sexes, in order to verify if asymptomatic carriers are randomly distributed or concentrated in some particular families and if there is preferential parental transmission (maternal or paternal) resulting in non-penetrant carriers. We have analysed a total of 506 individuals from 106 unrelated families with at least one affected facioscapulohumeral muscular dystrophy proband. In all patients the molecular diagnosis was confirmed following double digestion (Eco RI/Bln I fragment <35 kb). About 20% among probands' relatives who were found to carry the small fragment were asymptomatic or minimally affected, without preferential parental transmission, but with a significantly higher proportion of females (n=37) than males (n=14). Although asymptomatic carriers were found in about 30% of the families, some genealogies seem to concentrate more non-penetrant cases. A significant correlation between the size of the Eco RI fragment and severity of the phenotype was observed in the total sample but surprisingly this correlation is significant only among affected females. The gender difference in clinical manifestation as well as the observation that asymptomatic carriers are not rare should be taken into consideration in genetic counseling of affected patients or 'at-risk' relatives.
Similar articles
-
An inherited 4q35-EcoRI-DNA-fragment of 35 kb in a family with a sporadic case of facioscapulohumeral muscular dystrophy (FSHD).Neuromuscul Disord. 2000 Mar;10(3):178-81. doi: 10.1016/s0960-8966(99)00102-9. Neuromuscul Disord. 2000. PMID: 10734264
-
Facioscapulohumeral muscular dystrophy: new insights from compound heterozygotes and implication for prenatal genetic counselling.J Med Genet. 2012 Mar;49(3):171-8. doi: 10.1136/jmedgenet-2011-100454. Epub 2012 Jan 3. J Med Genet. 2012. PMID: 22217918
-
Mutation spectrum and phenotypic manifestation in FSHD Greek patients.Neuromuscul Disord. 2012 Apr;22(4):339-49. doi: 10.1016/j.nmd.2011.11.001. Epub 2012 Feb 21. Neuromuscul Disord. 2012. PMID: 22357364
-
[Facioscapulohumeral muscular dystrophy (FSHD)].Nihon Rinsho. 1997 Dec;55(12):3181-5. Nihon Rinsho. 1997. PMID: 9436432 Review. Japanese.
-
[Progress in researches on the molecular genetics of facioscapulohumeral muscular dystrophy].Zhonghua Yi Xue Yi Chuan Xue Za Zhi. 2001 Oct;18(5):398-401. Zhonghua Yi Xue Yi Chuan Xue Za Zhi. 2001. PMID: 11592052 Review. Chinese.
Cited by
-
Facioscapulohumeral Muscular Dystrophy: Update on Pathogenesis and Future Treatments.Neurotherapeutics. 2018 Oct;15(4):863-871. doi: 10.1007/s13311-018-00675-3. Neurotherapeutics. 2018. PMID: 30361930 Free PMC article. Review.
-
Progressive myocardial injury in myotonic dystrophy type II and facioscapulohumeral muscular dystrophy 1: a cardiovascular magnetic resonance follow-up study.J Cardiovasc Magn Reson. 2021 Nov 8;23(1):130. doi: 10.1186/s12968-021-00812-6. J Cardiovasc Magn Reson. 2021. PMID: 34743704 Free PMC article.
-
The FSHD2 gene SMCHD1 is a modifier of disease severity in families affected by FSHD1.Am J Hum Genet. 2013 Oct 3;93(4):744-51. doi: 10.1016/j.ajhg.2013.08.004. Epub 2013 Sep 26. Am J Hum Genet. 2013. PMID: 24075187 Free PMC article.
-
The cell biology of disease: FSHD: copy number variations on the theme of muscular dystrophy.J Cell Biol. 2010 Dec 13;191(6):1049-60. doi: 10.1083/jcb.201007028. J Cell Biol. 2010. PMID: 21149563 Free PMC article. Review.
-
DUX4 Signalling in the Pathogenesis of Facioscapulohumeral Muscular Dystrophy.Int J Mol Sci. 2020 Jan 22;21(3):729. doi: 10.3390/ijms21030729. Int J Mol Sci. 2020. PMID: 31979100 Free PMC article. Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources